← PG forward model

PG · Forward model · Corporate · Bear case

What has to happen in Corporate

Model as of

This page changes Corporate inside the complete PG model. Every other vertical, corporate programme and valuation assumption stays in the selected portfolio case.

PG forward model
Horizon
Consolidated fair value $100.64 all other verticals held in this portfolio case
Final-quarter revenue $292M 1% of company revenue
Explicit segment contribution −$1.72B EBITDA less segment capex, before corporate items

Guidance is not reached and the multiple goes with it. The June quarter printed 0% organic growth with volume, price and mix all flat, Baby, Feminine & Family Care fell 2% organic, and Health Care's Oral Care lost volume in both North America and Greater China. Against that, fiscal 2027 carries a disclosed ~$1bn after-tax cost headwind worth $0.56 a share, most of it in the first half, and the CFO has already said first-quarter EPS will be 'down 5% or more'. The 0.25pp a quarter this case removes from every line is itself disclosed arithmetic: roughly 0.15pp of the trailing rate is the fiscal 2026 currency tailwind that guidance sets to zero, and about 0.10pp is the 30 to 50 basis points of brand, product form and go-to-market discontinuations P&G has put inside its own organic guidance. Margins give back 100bp for the reinvestment step-up and the exit falls to 12x, roughly the 2018 staples de-rating. Fiscal 2027 net sales land at $86.90bn, 0.15% below fiscal 2026 and below the guided floor of $87.90bn, and fair value is $100.64.

Corporate

Basis quarter$292M
Final quarter$292M
Implied CAGR0%
Final revenue mix1%

Not a business. Corporate carries incidental businesses managed at the corporate level, divested-brand gains and losses, unallocated employee benefit and restructuring costs, asset impairments, interest expense and the reconciliation from segment blended statutory tax rates to the group effective rate. It is included as a revenue-bearing vertical only so that vertical revenue reconciles exactly to reported net sales.

Last four quarters
2025 Q3 $242M Reported
2025 Q4 $160M Reported
2026 Q1 $225M Reported
2026 Q2 $292M Reported
Incidental businesses managed at the corporate level
Sequential growth +0.2%/qtr decaying toward +0.2% Pinned at 0.25%/qtr, an assumption. The fitted 4.65% is a small-number artefact worth $391m of phantom FY2027 sales.
Corporate

Latest: $292M (2031Q2E)

Period Value
2021Q3 $138M
2021Q4 $152M
2022Q1 $215M
2022Q2 $239M
2022Q3 $253M
2022Q4 $175M
2023Q1 $173M
2023Q2 $164M
2023Q3 $144M
2023Q4 $126M
2024Q1 $128M
2024Q2 $203M
2024Q3 $163M
2024Q4 $159M
2025Q1 $198M
2025Q2 $274M
2025Q3 $242M
2025Q4 $160M
2026Q1 $225M
2026Q2 $292M
2026Q3E $292M
2026Q4E $292M
2027Q1E $292M
2027Q2E $292M
2027Q3E $292M
2027Q4E $292M
2028Q1E $292M
2028Q2E $292M
2028Q3E $292M
2028Q4E $292M
2029Q1E $292M
2029Q2E $292M
2029Q3E $292M
2029Q4E $292M
2030Q1E $292M
2030Q2E $292M
2030Q3E $292M
2030Q4E $292M
2031Q1E $292M
2031Q2E $292M

Assumptions & reasoning

  • Corporate is carried as a sixth revenue-bearing vertical because P&G reports $919m of Corporate net sales that have to be in the revenue reconciliation; excluding it would leave a 1.06% hole against reported consolidated net sales. It is not a business: it holds incidental businesses managed at the corporate level, divested-brand gains and losses, unallocated employee benefit and restructuring costs, asset impairments and interest.
  • Because this vertical already is the unallocated overhead, corporate.overheadPctRevenue is set to zero. Adding a second overhead line on top would count the same cost twice. The -96.74% EBITDA margin is (Corporate operating loss $(1,289)m + Corporate depreciation and amortisation $400m) / Corporate net sales $919m - a $889m cost on $919m of revenue, which is why the percentage is meaningless as a margin and correct as an arithmetic carrier.
  • The terminal margin of -15.23% is the one assumed margin change in the model. It removes the $749m of incremental restructuring P&G adjusted out of fiscal 2026 core earnings, because the Focused Portfolio, Supply Chain and Productivity Plan announced in June 2025 runs two years and P&G guides only $0.13 to $0.17 per share of non-core restructuring left in fiscal 2027. The ongoing $250-500m annual restructuring baseline stays in the line. The 0.35 glide closes 82% of that gap inside four quarters.
  • The trailing deseasonalised rate for this line is 4.65% a quarter, which is an artefact of a small residual that swings between $126m and $292m with no repeating pattern. Extrapolating it would add $391m of phantom revenue in fiscal 2027 and about $2.4bn by 2031, so growth is pinned at 0.25% a quarter as an explicit assumption.
PG model map

Explore another vertical